Huge progress on my hashimotos after decades on t4. If you still have symptoms with normal TSH, READ THIS
I'm writing a longer sub stack article but the gist of it is in the ai summary below:
The Opening Puzzle
- Diagnosed with Hashimoto's; on T4-only medication (levothyroxine), high dose (250mcg)
- Felt progressively "dumber" over time — but with intermittent windows of sharp creativity, fluent vocabulary, easy word-finding, like my younger self
- Standard labs "normal" (TSH ~2), antibodies improved (down from >1000 to 130) — so on paper, treated and fine
- Key anomaly: temporarily coming *off* medication sometimes made me feel *better* cognitively, not worse
The Initial Hypothesis
- Suspected the brain wasn't getting enough active thyroid hormone despite normal blood levels
- Core insight: TSH reflects what the *pituitary* sees, not what brain tissue experiences
- The brain runs almost entirely on T3 (active hormone), converted locally from T4 by the D2 enzyme
- If that conversion is impaired, the brain can be hypothyroid while bloodwork looks normal
Why the Dose Was a Red Flag
- 250mcg is a very high T4 requirement (standard is ~1.6mcg/kg)
- Ruled out absorption causes: negative H. pylori, no celiac (already gluten-free), tried empty-stomach dosing, good vitamin D/B12/ferritin, negative parietal cell antibodies + normal gastrin
- High dose + normal TSH + persistent symptoms suggested the problem wasn't substrate (T4) but conversion to active hormone
The Mechanisms Investigated
- Reverse T3 (rT3): high T4 gets shunted into inactive rT3, which occupies T3 receptors without activating them — a competitive antagonist
- DIO2 polymorphism: genetic variant impairing brain-specific T4→T3 conversion; silent in healthy people (they have backup T3 sources), but exposed in T4-only patients with a damaged gland who've lost those backups
- Tissue-specific hypothyroidism: liver/kidney (D1 enzyme) convert fine; brain (D2 enzyme) doesn't — different organs, different thyroid states from the same blood
The Genetic Evidence
- Pulled 2015 raw genetic data (from 23andme)
- **DIO2 rs225014: CT (heterozygous)** — confirmed one copy of the conversion-impairing variant
- **MTHFR A1298C +/+ (homozygous):** parallel issue — impairs BH4 production, the rate-limiting cofactor for dopamine/serotonin/norepinephrine synthesis
- **Slow MAO-A:** catecholamines clear slowly — relevant to both symptoms and later anxiety
- Two independent mechanisms converging on the same neurotransmitter systems that govern word-finding, creativity, emotional range
Mapping Symptoms to Brain Regions
- Hippocampus (highest D2 density): word-finding, memory retrieval
- Default Mode Network: divergent/creative associative thinking — the "younger self" mode
- Prefrontal cortex: working memory, task-switching (compounded by low dopamine)
- Cerebellum: verbal fluency, sentence construction
- Striatum: motivation, reward, libido, anhedonia
- All functionally under-resourced, not structurally damaged — reversible
Why Alcohol, LSD, Nicotine, Caffeine Were Diagnostic Clues
- Alcohol/LSD briefly restored "feeling normal" — because they bypass the synthesis bottleneck via direct receptor activation and DMN disruption
- Couldn't feel nicotine/caffeine before the fix — dopaminergic system too depleted to respond
- Effortless nicotine start/stop before treatment — low dopamine meant no reinforcement, so no addiction grip
- These weren't random; they were a functional readout of a depleted monoamine system
The Intervention (Phase 1)
- Added 5mcg T3 (liothyronine) directly — bypasses the broken conversion step
- Reduced T4 from 250 → 200mcg — cuts substrate feeding rT3
- Chose synthetic combo over NDT for precise, independent titration (and to avoid the T3-heavy NDT ratio, risky given slow MAO-A)
- 6-week lab cadence; tracked resting HR, HRV, sleep, symptoms
What Changed (Weeks 1-3)
- Week 2: dramatically better word-finding, sentence structure, analogies; more emotion-centered
- Libido normalized
- Started *feeling* nicotine and caffeine (dopamine system coming online)
- Deeper sleep, vivid dreams returning (REM recovery)
- Faster toenail growth (peripheral metabolic marker — hard to fake)
- Girlfriend independently noticed: more attentive, more "silly," more myself (external validation, no placebo bias)
- HRV rose from high-30s to low-50s and held
- Transient anxiety (slow MAO-A adaptation as catecholamines came up) — resolved on its own
- Improvements settled from peak to a sustainable plateau — not a reversal, and distinct from prior T4-reduction crashes because the mechanism was actually addressed this time
The Confirming Labs (Week 6)
- TSH 3.80 (up from 2.0 — proof the T4 cut outweighed the T3 add; not over-replaced)
- Free T4 1.7 (top of range — abundant substrate)
- Free T3 3.0 (only mid-range — poor output despite abundant substrate)
- Reverse T3 24 (top of range — substrate being shunted to inactive hormone)
- FT3:rT3 ratio 1.25 (target >2.0 — quantified conversion failure)
- SHBG 65 (high despite TRT lowering it — liver is thyroid-replete while brain isn't: the regional dissociation made visible)
- hsCRP <0.2, cortisol 12.0 — ruled out inflammation and HPA dysfunction as confounders
- Every number told one consistent story: impaired conversion + reverse T3 dominance + tissue-specific hypothyroidism
The Takeaways
- "Normal TSH" does not mean optimized — it reflects pituitary status, not brain tissue
- A poor FT3:rT3 ratio can hide behind normal standard labs
- Genetics (DIO2, MTHFR) explain why identical treatment fails some people and works for others
- Direct T3 isn't a workaround for the root cause — for impaired conversion, it *is* the mechanistically correct fix
- The cognitive/emotional "self" that seemed lost was never gone — it was an under-fueled system, and the fuel was the missing active hormone
- n=1, self-directed, but every layer (symptoms, genetics, substances, labs, external observation, objective markers) independently pointed the same direction
Phase 2 (in progress)
- T4 → 150mcg, T3 → 10mcg split BID
- Targets: FT3 upper-third, rT3 mid-teens, ratio >2, SHBG trending, TSH with headroom
- Plus methylation support (5-MTHF, methyl/adenosyl B12, R5P) for the parallel BH4 pathway
I hope this helps people